A company based in Farmington, Connecticut, that develops skin disease treatments using microbiome science and technology.
Azitra's platform uses a strain of bacteria from the skin microbiome, S. epidermidis, to modify the skin microbiome and deliver therapeutic protein to the target. The platform is modular and can modify S. epidermidis to secrete an array of therapeutically relevant proteins necessary in the treatment of multiple skin diseases.